Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SUM1315MO2 | Volasertib | PLK | Cell cycle | 0.0095 | -0.3877 | 0.6658 | 0.2263 | 2.3240 | 0.012143 | 0.99552 |
SUM1315MO2 | Dinaciclib | pan CDK | Cell cycle | 0.010938 | -0.6674 | 0.7696 | 0.2780 | 4.1442 | 0.013399 | 0.99826 |
SUM1315MO2 | Cisplatin | Chemo | Chemotherapy | 1.275 | 0.2028 | 0.2961 | 0.0592 | 0.4798 | 3.6243 | 0.95111 |
SUM1315MO2 | Doxorubicin | Chemo | Chemotherapy | 0.018222 | -0.0635 | 0.5132 | 0.1324 | 2.0980 | 0.016338 | 0.96491 |
SUM1315MO2 | Taxol | Chemo | Chemotherapy | 0.0024623 | -0.3258 | 0.7931 | 0.2940 | 2.0093 | 0.0030737 | 0.99498 |
SUM1315MO2 | Topotecan | Topo I | Chemotherapy | 0.011771 | -0.3317 | 0.7690 | 0.2174 | 0.3263 | 0.11949 | 0.94357 |
SUM1315MO2 | Etoposide | Topo II | Chemotherapy | 0.29244 | 0.0416 | 0.3833 | 0.1087 | 0.7536 | 0.26458 | 0.97369 |
SUM1315MO2 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.019122 | -0.2366 | 0.7398 | 0.1323 | 0.4601 | 0.063919 | 0.98963 |
SUM1315MO2 | Trametinib | MEK | MAPK/nRTK | 0.021115 | 0.1329 | 0.3887 | 0.0532 | 1.0540 | 0.01638 | 0.99458 |
SUM1315MO2 | Saracatinib | SRC | MAPK/nRTK | 1.3921 | 0.0846 | 0.2439 | 0.0407 | 0.7066 | 2.4563 | 0.99551 |
SUM1315MO2 | ABT-737 | Bcl2/XL | Misc | 5.9406 | 0.3056 | 0.0987 | 0.0360 | 0.8016 | 23.3924 | 0.93756 |
SUM1315MO2 | Vorinostat | HDAC | Misc | 1.7621 | -0.0668 | 0.1742 | 0.0660 | 2.7811 | 1.8526 | 0.9927 |
SUM1315MO2 | Luminespib | HSP90 | Misc | 0.0048627 | -0.0810 | 0.6112 | 0.1374 | 5.0000 | 0.0050309 | 0.99738 |
SUM1315MO2 | A-1210477 | Mcl-1 | Misc | Inf | 0.7399 | -0.0234 | -0.0009 | 3.9393 | 9.1387 | 0.79269 |
SUM1315MO2 | Olaparib | PARP | Misc | 2.0295 | 0.0911 | 0.2452 | 0.0432 | 0.5075 | 17.6824 | 0.94995 |
SUM1315MO2 | Bleomycin | Radiation | Misc | 0.21351 | 0.1491 | 0.4103 | 0.1246 | 0.8125 | 0.15089 | 0.9779 |
SUM1315MO2 | Ipatasertib | AKT | PI3K/mTOR | 36.6304 | 0.6070 | 0.1242 | 0.0099 | 0.3263 | 999.2697 | 0.9146 |
SUM1315MO2 | Alpelisib | PI3Ka | PI3K/mTOR | 6.462 | 0.3829 | 0.1169 | 0.0203 | 0.5997 | 40.3568 | 0.94056 |
SUM1315MO2 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.51622 | 0.0942 | 0.3970 | 0.0476 | 0.2926 | 22.0638 | 0.995 |
SUM1315MO2 | TGX221 | PI3Kb | PI3K/mTOR | Inf | 0.7054 | 0.1362 | 0.0073 | 0.9367 | 0.077385 | 0.83645 |
SUM1315MO2 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.015037 | -0.0903 | 0.4863 | 0.0621 | 0.7079 | 0.022637 | 0.99665 |
SUM1315MO2 | Everolimus | mTOR1 | PI3K/mTOR | Inf | 0.4018 | 0.4539 | 0.0330 | 0.0000 | Inf | 0.42807 |
SUM1315MO2 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0065863 | 0.0256 | 0.6471 | 0.0662 | 0.8616 | 0.0061137 | 0.99691 |
SUM1315MO2 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.5951 | 0.0977 | 0.0059 | 0.9518 | 1.3643 | 0.93531 |
SUM1315MO2 | Buparlisib | pan PI3K | PI3K/mTOR | 0.40124 | -0.3686 | 0.4388 | 0.1149 | 0.9148 | 0.94031 | 0.98014 |